Evercore ISI Group Maintains Outperform on Amphenol, Raises Price Target to $100
Evercore ISI Group analyst Amit Daryanani maintains Amphenol (NYSE:APH) with a Outperform and raises the price target from $90 to $100.
Economy · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Evercore ISI Group analyst Amit Daryanani maintains Amphenol (NYSE:APH) with a Outperform and raises the price target from $90 to $100.
NVIDIA and Cisco announced Ultra-Dense Small Form Factor Pluggable (USFP), a new 400Gb/s-per-lane optical module designed for next-generation AI factories. USFP delivers 4x the bandwidth density and 1.3x power efficiency compared to 200Gb/s-per-lane optics, enabling AI infrastructure to scale compute without adding network tiers. The companies are collaborating with TE Connectivity and Amphenol to build a multi-source hardware ecosystem around the technology.
CIBC initiates coverage on Constellation Energy (NASDAQ:CEG) with a Outperformer rating and announces Price Target of $358.
AI data centers face a significant electricity shortage, with the U.S. alone projected to have a 32-gigawatt shortfall by 2028. The article identifies seven stocks positioned to benefit from this power crisis: utility companies with nuclear capabilities (Constellation Energy, NextEra Energy, Vistra), equipment manufacturers for power generation and management (GE Vernova, Bloom Energy, Eaton, Vertiv). These companies are capitalizing on growing demand for alternative power solutions and energy-efficient infrastructure.
Oklo is developing small nuclear reactors to power AI data centers and reduce fossil fuel dependence. While the company has secured support from Meta and other tech companies, it remains highly speculative with no commercial reactors deployed yet. For investors to become millionaires, the stock would need to gain 100-fold, making it an unrealistic expectation given the company's current stage and regulatory hurdles.